|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 07812295.9 (espacenet) (Federated) (European Patent Register), 20070625 | | Patent/reg. no. and date | DK/EP 2040548, 20120502 | | Publication date | 20090401 | | Priority no. and date | US 815952 P, 20060623 | | EP pub. no. and date |
EP 2040548 20090401 | | Effective date | | | Applicant/owner | Amicus Therapeutics, Inc., 6 Cedar Brook Drive
Cranbury, NJ 08512, US | | Applicant ref. no. | AMIC EP07812295.9 | | Inventor | WUSTMAN, Brandon, 119 Commonwealth Court
Apt. 10
Princeton, NJ 08540, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/45 (2006.01) | | Title | Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase | | Int. application no. | US2007072016 | | Int. publication no. | WO2007150064 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
